Top Markets
Coin of the day
NexgenRx Inc. NexgenRx Inc.

NexgenRx Inc.

NEGXF
Peringkat dalam Saham #29067
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a... NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada. Beyond core claims handling, NexgenRx offers Health Care Spending Accounts (HCSAs), providing individuals with dedicated funds for their health or dental expenses. Its service portfolio also encompasses individual and aggregate stop-loss insurance products, emergency medical and travel assistance insurance, and a suite of administrative support functions. These administrative services include the collection and disbursement of premiums for life and long-term disability (LTD) coverage, complemented by advanced reporting tools. To enhance convenience, the company facilitates online claims submission and direct deposit services, along with other specialized ancillary services.
Harga Saham
$0.325
Terakhir disinkronkan: 2026-08-18
Kapitalisasi Pasar
$23.11M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
62.50%
Negara
CA
Perdagangan NexgenRx Inc. (NEGXF)

Kategori

Laba untuk NexgenRx Inc. (NEGXF)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari NexgenRx Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk NexgenRx Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$17.44B -
US
$5.79B -
US
$5.86B -
US
$8.45B -
US
$1.61B -
US